These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11041712)

  • 1. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    Tan TY; Pitman I; Penrose-Stevens A; Simpson BA; Flanagan PG
    J Infect; 2000 Jul; 41(1):95-7. PubMed ID: 11041712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Tush GM; Huneycutt S; Phillips A; Ward JD
    Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
    Linden PK; Pasculle AW; McDevitt D; Kramer DJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
    Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
    Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin].
    Maseda E; Uña R; Ureta P; Royo C
    Med Clin (Barc); 2002 Sep; 119(7):276-7. PubMed ID: 12236991
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
    McNeil SA; Clark NM; Chandrasekar PH; Kauffman CA
    Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
    Kanchanapoom T; Koirala J; Goodrich J; Agamah E; Khardori N
    Diagn Microbiol Infect Dis; 2003 Mar; 45(3):213-5. PubMed ID: 12663164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
    Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
    Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
    J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.
    Aeschlimann JR; Zervos MJ; Rybak MJ
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2710-7. PubMed ID: 9756782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.